Global Infectious Disease Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028 - Market Study Report

Global Infectious Disease Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Format: PDF | Report ID: 5436301 | Published Date: August 06, 2022

Choose License
The Infectious Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Infectious Disease Diagnostics market size is estimated to be worth US$ 3749.5 million in 2021 and is forecast to a readjusted size of USD 4972.4 million by 2028 with a CAGR of 4.1% during review period. Hepatitis C accounting for  % of the Infectious Disease Diagnostics global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Molecular Diagnostic Technique segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Infectious Disease Diagnostics include Bio M?(C)rieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, and BD, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Infectious Disease Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Molecular Diagnostic Technique
    Traditional Diagnostic Technique
Market segment by Application, can be divided into
    Hepatitis C
    Hepatitis B
    Tuberculosis (TB)
    Acquired Immunodeficiency Syndrome (AIDS)
    Human Papillomavirus (HPV)
    Methicillin-resistant Staphylococcus Aureus (MRSA)
Market segment by players, this report covers
    Bio M?(C)rieux SA
    Roche Diagnostics
    Abbott Laboratories
    Thermo Fischer Scientific
    BD
    Bio-Rad Laboratories
    Abbott
    Danaher
    Johnson and Johnson
    Guangzhou Wondfo Biotech Co.,Ltd.
    Getein Biotech, Inc.
    Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
    BGI Genomics Co.,Ltd.
    Maccura Biotechnology Co.,Ltd.
    Daan Gene
    Beijing Strong Biotechnologies,Inc
    Shanghai Kehua Bio-Engineering Co.,Ltd.
    Guangdong Hybribio Biotech Co.,Ltd.
    Shanghai Runda Medical Technology Co.,Ltd.
    Tellgen Corporation
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Infectious Disease Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Infectious Disease Diagnostics, with revenue, gross margin and global market share of Infectious Disease Diagnostics from 2019 to 2022.
Chapter 3, the Infectious Disease Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Infectious Disease Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Infectious Disease Diagnostics research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Product Overview and Scope of Infectious Disease Diagnostics
    1.2 Classification of Infectious Disease Diagnostics by Type
        1.2.1 Overview: Global Infectious Disease Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Infectious Disease Diagnostics Revenue Market Share by Type in 2021
        1.2.3 Molecular Diagnostic Technique
        1.2.4 Traditional Diagnostic Technique
    1.3 Global Infectious Disease Diagnostics Market by Application
        1.3.1 Overview: Global Infectious Disease Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hepatitis C
        1.3.3 Hepatitis B
        1.3.4 Tuberculosis (TB)
        1.3.5 Acquired Immunodeficiency Syndrome (AIDS)
        1.3.6 Human Papillomavirus (HPV)
        1.3.7 Methicillin-resistant Staphylococcus Aureus (MRSA)
    1.4 Global Infectious Disease Diagnostics Market Size & Forecast
    1.5 Global Infectious Disease Diagnostics Market Size and Forecast by Region
        1.5.1 Global Infectious Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Infectious Disease Diagnostics Market Size by Region, (2017-2022)
        1.5.3 North America Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
        1.5.4 Europe Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
        1.5.6 South America Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Infectious Disease Diagnostics Market Drivers
        1.6.2 Infectious Disease Diagnostics Market Restraints
        1.6.3 Infectious Disease Diagnostics Trends Analysis
2 Company Profiles
    2.1 Bio M?(C)rieux SA
        2.1.1 Bio M?(C)rieux SA Details
        2.1.2 Bio M?(C)rieux SA Major Business
        2.1.3 Bio M?(C)rieux SA Infectious Disease Diagnostics Product and Solutions
        2.1.4 Bio M?(C)rieux SA Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Bio M?(C)rieux SA Recent Developments and Future Plans
    2.2 Roche Diagnostics
        2.2.1 Roche Diagnostics Details
        2.2.2 Roche Diagnostics Major Business
        2.2.3 Roche Diagnostics Infectious Disease Diagnostics Product and Solutions
        2.2.4 Roche Diagnostics Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Roche Diagnostics Recent Developments and Future Plans
    2.3 Abbott Laboratories
        2.3.1 Abbott Laboratories Details
        2.3.2 Abbott Laboratories Major Business
        2.3.3 Abbott Laboratories Infectious Disease Diagnostics Product and Solutions
        2.3.4 Abbott Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Abbott Laboratories Recent Developments and Future Plans
    2.4 Thermo Fischer Scientific
        2.4.1 Thermo Fischer Scientific Details
        2.4.2 Thermo Fischer Scientific Major Business
        2.4.3 Thermo Fischer Scientific Infectious Disease Diagnostics Product and Solutions
        2.4.4 Thermo Fischer Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Thermo Fischer Scientific Recent Developments and Future Plans
    2.5 BD
        2.5.1 BD Details
        2.5.2 BD Major Business
        2.5.3 BD Infectious Disease Diagnostics Product and Solutions
        2.5.4 BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 BD Recent Developments and Future Plans
    2.6 Bio-Rad Laboratories
        2.6.1 Bio-Rad Laboratories Details
        2.6.2 Bio-Rad Laboratories Major Business
        2.6.3 Bio-Rad Laboratories Infectious Disease Diagnostics Product and Solutions
        2.6.4 Bio-Rad Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
    2.7 Abbott
        2.7.1 Abbott Details
        2.7.2 Abbott Major Business
        2.7.3 Abbott Infectious Disease Diagnostics Product and Solutions
        2.7.4 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Abbott Recent Developments and Future Plans
    2.8 Danaher
        2.8.1 Danaher Details
        2.8.2 Danaher Major Business
        2.8.3 Danaher Infectious Disease Diagnostics Product and Solutions
        2.8.4 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Danaher Recent Developments and Future Plans
    2.9 Johnson and Johnson
        2.9.1 Johnson and Johnson Details
        2.9.2 Johnson and Johnson Major Business
        2.9.3 Johnson and Johnson Infectious Disease Diagnostics Product and Solutions
        2.9.4 Johnson and Johnson Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Johnson and Johnson Recent Developments and Future Plans
    2.10 Guangzhou Wondfo Biotech Co.,Ltd. 
        2.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
        2.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
        2.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
        2.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments and Future Plans
    2.11 Getein Biotech, Inc.
        2.11.1 Getein Biotech, Inc. Details
        2.11.2 Getein Biotech, Inc. Major Business
        2.11.3 Getein Biotech, Inc. Infectious Disease Diagnostics Product and Solutions
        2.11.4 Getein Biotech, Inc. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Getein Biotech, Inc. Recent Developments and Future Plans
    2.12 Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
        2.12.1 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Details
        2.12.2 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Major Business
        2.12.3 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
        2.12.4 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Developments and Future Plans
    2.13 BGI Genomics Co.,Ltd.
        2.13.1 BGI Genomics Co.,Ltd. Details
        2.13.2 BGI Genomics Co.,Ltd. Major Business
        2.13.3 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
        2.13.4 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 BGI Genomics Co.,Ltd. Recent Developments and Future Plans
    2.14 Maccura Biotechnology Co.,Ltd.
        2.14.1 Maccura Biotechnology Co.,Ltd. Details
        2.14.2 Maccura Biotechnology Co.,Ltd. Major Business
        2.14.3 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
        2.14.4 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Maccura Biotechnology Co.,Ltd. Recent Developments and Future Plans
    2.15 Daan Gene
        2.15.1 Daan Gene Details
        2.15.2 Daan Gene Major Business
        2.15.3 Daan Gene Infectious Disease Diagnostics Product and Solutions
        2.15.4 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Daan Gene Recent Developments and Future Plans
    2.16 Beijing Strong Biotechnologies,Inc
        2.16.1 Beijing Strong Biotechnologies,Inc Details
        2.16.2 Beijing Strong Biotechnologies,Inc Major Business
        2.16.3 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Product and Solutions
        2.16.4 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Beijing Strong Biotechnologies,Inc Recent Developments and Future Plans
    2.17 Shanghai Kehua Bio-Engineering Co.,Ltd.
        2.17.1 Shanghai Kehua Bio-Engineering Co.,Ltd. Details
        2.17.2 Shanghai Kehua Bio-Engineering Co.,Ltd. Major Business
        2.17.3 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
        2.17.4 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Developments and Future Plans
    2.18 Guangdong Hybribio Biotech Co.,Ltd.
        2.18.1 Guangdong Hybribio Biotech Co.,Ltd. Details
        2.18.2 Guangdong Hybribio Biotech Co.,Ltd. Major Business
        2.18.3 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
        2.18.4 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 Guangdong Hybribio Biotech Co.,Ltd. Recent Developments and Future Plans
    2.19 Shanghai Runda Medical Technology Co.,Ltd.
        2.19.1 Shanghai Runda Medical Technology Co.,Ltd. Details
        2.19.2 Shanghai Runda Medical Technology Co.,Ltd. Major Business
        2.19.3 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
        2.19.4 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.19.5 Shanghai Runda Medical Technology Co.,Ltd. Recent Developments and Future Plans
    2.20 Tellgen Corporation
        2.20.1 Tellgen Corporation Details
        2.20.2 Tellgen Corporation Major Business
        2.20.3 Tellgen Corporation Infectious Disease Diagnostics Product and Solutions
        2.20.4 Tellgen Corporation Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.20.5 Tellgen Corporation Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Infectious Disease Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Infectious Disease Diagnostics Players Market Share in 2021
        3.2.2 Top 10 Infectious Disease Diagnostics Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Infectious Disease Diagnostics Players Head Office, Products and Services Provided
    3.4 Infectious Disease Diagnostics Mergers & Acquisitions
    3.5 Infectious Disease Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Infectious Disease Diagnostics Revenue and Market Share by Type (2017-2022)
    4.2 Global Infectious Disease Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Infectious Disease Diagnostics Revenue Market Share by Application (2017-2022)
    5.2 Global Infectious Disease Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Infectious Disease Diagnostics Revenue by Type (2017-2028)
    6.2 North America Infectious Disease Diagnostics Revenue by Application (2017-2028)
    6.3 North America Infectious Disease Diagnostics Market Size by Country
        6.3.1 North America Infectious Disease Diagnostics Revenue by Country (2017-2028)
        6.3.2 United States Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        6.3.3 Canada Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        6.3.4 Mexico Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Infectious Disease Diagnostics Revenue by Type (2017-2028)
    7.2 Europe Infectious Disease Diagnostics Revenue by Application (2017-2028)
    7.3 Europe Infectious Disease Diagnostics Market Size by Country
        7.3.1 Europe Infectious Disease Diagnostics Revenue by Country (2017-2028)
        7.3.2 Germany Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        7.3.3 France Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        7.3.5 Russia Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        7.3.6 Italy Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Infectious Disease Diagnostics Revenue by Type (2017-2028)
    8.2 Asia-Pacific Infectious Disease Diagnostics Revenue by Application (2017-2028)
    8.3 Asia-Pacific Infectious Disease Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Infectious Disease Diagnostics Revenue by Region (2017-2028)
        8.3.2 China Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        8.3.3 Japan Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        8.3.4 South Korea Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        8.3.5 India Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        8.3.7 Australia Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Infectious Disease Diagnostics Revenue by Type (2017-2028)
    9.2 South America Infectious Disease Diagnostics Revenue by Application (2017-2028)
    9.3 South America Infectious Disease Diagnostics Market Size by Country
        9.3.1 South America Infectious Disease Diagnostics Revenue by Country (2017-2028)
        9.3.2 Brazil Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        9.3.3 Argentina Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Infectious Disease Diagnostics Revenue by Type (2017-2028)
    10.2 Middle East & Africa Infectious Disease Diagnostics Revenue by Application (2017-2028)
    10.3 Middle East & Africa Infectious Disease Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Infectious Disease Diagnostics Revenue by Country (2017-2028)
        10.3.2 Turkey Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
        10.3.4 UAE Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Infectious Disease Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028 Table 2. Global Infectious Disease Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028 Table 3. Global Market Infectious Disease Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028) Table 4. Global Infectious Disease Diagnostics Revenue (USD Million) by Region (2017-2022) Table 5. Global Infectious Disease Diagnostics Revenue Market Share by Region (2023-2028) Table 6. Bio M?(C)rieux SA Corporate Information, Head Office, and Major Competitors Table 7. Bio M?(C)rieux SA Major Business Table 8. Bio M?(C)rieux SA Infectious Disease Diagnostics Product and Solutions Table 9. Bio M?(C)rieux SA Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 10. Roche Diagnostics Corporate Information, Head Office, and Major Competitors Table 11. Roche Diagnostics Major Business Table 12. Roche Diagnostics Infectious Disease Diagnostics Product and Solutions Table 13. Roche Diagnostics Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors Table 15. Abbott Laboratories Major Business Table 16. Abbott Laboratories Infectious Disease Diagnostics Product and Solutions Table 17. Abbott Laboratories Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 18. Thermo Fischer Scientific Corporate Information, Head Office, and Major Competitors Table 19. Thermo Fischer Scientific Major Business Table 20. Thermo Fischer Scientific Infectious Disease Diagnostics Product and Solutions Table 21. Thermo Fischer Scientific Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 22. BD Corporate Information, Head Office, and Major Competitors Table 23. BD Major Business Table 24. BD Infectious Disease Diagnostics Product and Solutions Table 25. BD Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 26. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors Table 27. Bio-Rad Laboratories Major Business Table 28. Bio-Rad Laboratories Infectious Disease Diagnostics Product and Solutions Table 29. Bio-Rad Laboratories Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 30. Abbott Corporate Information, Head Office, and Major Competitors Table 31. Abbott Major Business Table 32. Abbott Infectious Disease Diagnostics Product and Solutions Table 33. Abbott Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 34. Danaher Corporate Information, Head Office, and Major Competitors Table 35. Danaher Major Business Table 36. Danaher Infectious Disease Diagnostics Product and Solutions Table 37. Danaher Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 38. Johnson and Johnson Corporate Information, Head Office, and Major Competitors Table 39. Johnson and Johnson Major Business Table 40. Johnson and Johnson Infectious Disease Diagnostics Product and Solutions Table 41. Johnson and Johnson Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 42. Guangzhou Wondfo Biotech Co.,Ltd. Corporate Information, Head Office, and Major Competitors Table 43. Guangzhou Wondfo Biotech Co.,Ltd. Major Business Table 44. Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions Table 45. Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 46. Getein Biotech, Inc. Corporate Information, Head Office, and Major Competitors Table 47. Getein Biotech, Inc. Major Business Table 48. Getein Biotech, Inc. Infectious Disease Diagnostics Product and Solutions Table 49. Getein Biotech, Inc. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 50. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Corporate Information, Head Office, and Major Competitors Table 51. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Major Business Table 52. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Product and Solutions Table 53. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 54. BGI Genomics Co.,Ltd. Corporate Information, Head Office, and Major Competitors Table 55. BGI Genomics Co.,Ltd. Major Business Table 56. BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Product and Solutions Table 57. BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 58. Maccura Biotechnology Co.,Ltd. Corporate Information, Head Office, and Major Competitors Table 59. Maccura Biotechnology Co.,Ltd. Major Business Table 60. Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions Table 61. Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 62. Daan Gene Corporate Information, Head Office, and Major Competitors Table 63. Daan Gene Major Business Table 64. Daan Gene Infectious Disease Diagnostics Product and Solutions Table 65. Daan Gene Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 66. Beijing Strong Biotechnologies,Inc Corporate Information, Head Office, and Major Competitors Table 67. Beijing Strong Biotechnologies,Inc Major Business Table 68. Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Product and Solutions Table 69. Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 70. Shanghai Kehua Bio-Engineering Co.,Ltd. Corporate Information, Head Office, and Major Competitors Table 71. Shanghai Kehua Bio-Engineering Co.,Ltd. Major Business Table 72. Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Product and Solutions Table 73. Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 74. Guangdong Hybribio Biotech Co.,Ltd. Corporate Information, Head Office, and Major Competitors Table 75. Guangdong Hybribio Biotech Co.,Ltd. Major Business Table 76. Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions Table 77. Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 78. Shanghai Runda Medical Technology Co.,Ltd. Corporate Information, Head Office, and Major Competitors Table 79. Shanghai Runda Medical Technology Co.,Ltd. Major Business Table 80. Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions Table 81. Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 82. Tellgen Corporation Corporate Information, Head Office, and Major Competitors Table 83. Tellgen Corporation Major Business Table 84. Tellgen Corporation Infectious Disease Diagnostics Product and Solutions Table 85. Tellgen Corporation Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 86. Global Infectious Disease Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022) Table 87. Global Infectious Disease Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022) Table 88. Breakdown of Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) Table 89. Infectious Disease Diagnostics Players Head Office, Products and Services Provided Table 90. Infectious Disease Diagnostics Mergers & Acquisitions in the Past Five Years Table 91. Infectious Disease Diagnostics New Entrants and Expansion Plans Table 92. Global Infectious Disease Diagnostics Revenue (USD Million) by Type (2017-2022) Table 93. Global Infectious Disease Diagnostics Revenue Share by Type (2017-2022) Table 94. Global Infectious Disease Diagnostics Revenue Forecast by Type (2023-2028) Table 95. Global Infectious Disease Diagnostics Revenue by Application (2017-2022) Table 96. Global Infectious Disease Diagnostics Revenue Forecast by Application (2023-2028) Table 97. North America Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million) Table 98. North America Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million) Table 99. North America Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million) Table 100. North America Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million) Table 101. North America Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million) Table 102. North America Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million) Table 103. Europe Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million) Table 104. Europe Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million) Table 105. Europe Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million) Table 106. Europe Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million) Table 107. Europe Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million) Table 108. Europe Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million) Table 109. Asia-Pacific Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million) Table 110. Asia-Pacific Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million) Table 111. Asia-Pacific Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million) Table 112. Asia-Pacific Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million) Table 113. Asia-Pacific Infectious Disease Diagnostics Revenue by Region (2017-2022) & (USD Million) Table 114. Asia-Pacific Infectious Disease Diagnostics Revenue by Region (2023-2028) & (USD Million) Table 115. South America Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million) Table 116. South America Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million) Table 117. South America Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million) Table 118. South America Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million) Table 119. South America Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million) Table 120. South America Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million) Table 121. Middle East & Africa Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million) Table 122. Middle East & Africa Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million) Table 123. Middle East & Africa Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million) Table 124. Middle East & Africa Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million) Table 125. Middle East & Africa Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million) Table 126. Middle East & Africa Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million) List of Figures Figure 1. Infectious Disease Diagnostics Picture Figure 2. Global Infectious Disease Diagnostics Revenue Market Share by Type in 2021 Figure 3. Molecular Diagnostic Technique Figure 4. Traditional Diagnostic Technique Figure 5. Infectious Disease Diagnostics Revenue Market Share by Application in 2021 Figure 6. Hepatitis C Picture Figure 7. Hepatitis B Picture Figure 8. Tuberculosis (TB) Picture Figure 9. Acquired Immunodeficiency Syndrome (AIDS) Picture Figure 10. Human Papillomavirus (HPV) Picture Figure 11. Methicillin-resistant Staphylococcus Aureus (MRSA) Picture Figure 12. Global Infectious Disease Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028 Figure 13. Global Infectious Disease Diagnostics Revenue and Forecast (2017-2028) & (USD Million) Figure 14. Global Infectious Disease Diagnostics Revenue Market Share by Region (2017-2028) Figure 15. Global Infectious Disease Diagnostics Revenue Market Share by Region in 2021 Figure 16. North America Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028) Figure 17. Europe Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028) Figure 18. Asia-Pacific Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028) Figure 19. South America Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028) Figure 20. Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028) Figure 21. Infectious Disease Diagnostics Market Drivers Figure 22. Infectious Disease Diagnostics Market Restraints Figure 23. Infectious Disease Diagnostics Market Trends Figure 24. Bio M?(C)rieux SA Recent Developments and Future Plans Figure 25. Roche Diagnostics Recent Developments and Future Plans Figure 26. Abbott Laboratories Recent Developments and Future Plans Figure 27. Thermo Fischer Scientific Recent Developments and Future Plans Figure 28. BD Recent Developments and Future Plans Figure 29. Bio-Rad Laboratories Recent Developments and Future Plans Figure 30. Abbott Recent Developments and Future Plans Figure 31. Danaher Recent Developments and Future Plans Figure 32. Johnson and Johnson Recent Developments and Future Plans Figure 33. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments and Future Plans Figure 34. Getein Biotech, Inc. Recent Developments and Future Plans Figure 35. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Developments and Future Plans Figure 36. BGI Genomics Co.,Ltd. Recent Developments and Future Plans Figure 37. Maccura Biotechnology Co.,Ltd. Recent Developments and Future Plans Figure 38. Daan Gene Recent Developments and Future Plans Figure 39. Beijing Strong Biotechnologies,Inc Recent Developments and Future Plans Figure 40. Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Developments and Future Plans Figure 41. Guangdong Hybribio Biotech Co.,Ltd. Recent Developments and Future Plans Figure 42. Shanghai Runda Medical Technology Co.,Ltd. Recent Developments and Future Plans Figure 43. Tellgen Corporation Recent Developments and Future Plans Figure 44. Global Infectious Disease Diagnostics Revenue Share by Players in 2021 Figure 45. Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021 Figure 46. Global Top 3 Players Infectious Disease Diagnostics Revenue Market Share in 2021 Figure 47. Global Top 10 Players Infectious Disease Diagnostics Revenue Market Share in 2021 Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022) Figure 49. Global Infectious Disease Diagnostics Revenue Share by Type in 2021 Figure 50. Global Infectious Disease Diagnostics Market Share Forecast by Type (2023-2028) Figure 51. Global Infectious Disease Diagnostics Revenue Share by Application in 2021 Figure 52. Global Infectious Disease Diagnostics Market Share Forecast by Application (2023-2028) Figure 53. North America Infectious Disease Diagnostics Sales Market Share by Type (2017-2028) Figure 54. North America Infectious Disease Diagnostics Sales Market Share by Application (2017-2028) Figure 55. North America Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028) Figure 56. United States Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 57. Canada Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 58. Mexico Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. Europe Infectious Disease Diagnostics Sales Market Share by Type (2017-2028) Figure 60. Europe Infectious Disease Diagnostics Sales Market Share by Application (2017-2028) Figure 61. Europe Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028) Figure 62. Germany Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 63. France Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 64. United Kingdom Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 65. Russia Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 66. Italy Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 67. Asia-Pacific Infectious Disease Diagnostics Sales Market Share by Type (2017-2028) Figure 68. Asia-Pacific Infectious Disease Diagnostics Sales Market Share by Application (2017-2028) Figure 69. Asia-Pacific Infectious Disease Diagnostics Revenue Market Share by Region (2017-2028) Figure 70. China Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 71. Japan Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 72. South Korea Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 73. India Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 74. Southeast Asia Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. Australia Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 76. South America Infectious Disease Diagnostics Sales Market Share by Type (2017-2028) Figure 77. South America Infectious Disease Diagnostics Sales Market Share by Application (2017-2028) Figure 78. South America Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028) Figure 79. Brazil Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 80. Argentina Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 81. Middle East and Africa Infectious Disease Diagnostics Sales Market Share by Type (2017-2028) Figure 82. Middle East and Africa Infectious Disease Diagnostics Sales Market Share by Application (2017-2028) Figure 83. Middle East and Africa Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028) Figure 84. Turkey Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 85. Saudi Arabia Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 86. UAE Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 87. Methodology Figure 88. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us